NATURAL ALTERNATIVES INTERNATIONAL INC
Close on Oct 19, 2026
- Market cap
- $6.98M
- P/E (TTM)
- –
- Dividend yield
- –
About Natural Alternatives International
Medicinal Chemicals & Botanical Products, SIC 2833
Natural Alternatives International, Inc. formulates, manufactures, and markets nutritional supplements, operating through two segments: private-label contract manufacturing and patent and trademark licensing. As its primary business activity, the company provides contract manufacturing services to businesses that distribute vitamins, minerals, herbal supplements, and health care items to consumers. Its product formats include tablets, capsules, powders, and chewable wafers, supported by services such as custom formulation, clinical study design, packaging, and regulatory assistance. It also commercializes a patent estate centered on the raw material beta-alanine under brands including CarnoSyn, SR CarnoSyn, CarnoSyn 4X, and TriBsyn through raw material sales and licensing agreements.
The company maintains corporate headquarters in Carlsbad, California, alongside a dedicated powder blending and packaging facility, with another manufacturing facility situated in nearby Vista, California. Internationally, its European subsidiary operates an analytical laboratory, manufacturing, packaging, and distribution facility in Manno, Switzerland. Its contract manufactured goods reach consumers across the United States and international markets, primarily Europe and Asia, as well as Australia, Mexico, and Canada.
Summary of the business section of Natural Alternatives International's latest annual report, written by StockData.
Company profile
Company
- Legal name
- NATURAL ALTERNATIVES INTERNATIONAL INC
- Founded
- 1980
- Headquarters
- Carlsbad, CA
- Address
- 1535 Faraday Avenue 92008-7319
- Phone
- (760) 736-7700
- Website
- www.nai-online.com
- Employees
- 219, Jun 30, 2026
- Industry
- Medicinal Chemicals & Botanical Products
- Incorporated in
- Delaware
- Fiscal year ends
- June 30
- Auditor
- HASKELL & WHITE LLP, Irvine, California
Stock & identifiers
- Ticker
- NAII
- Exchange
- Nasdaq
- IPO date
- Oct 28, 1993
- Shares outstanding
- 22M, Sep 28, 2026
- Public float
- $6.26M, Dec 31, 2025
- Filer category
- Non-accelerated filer<br>Smaller reporting company
- SEC CIK
- 787253
- CUSIP
- 638842302
- ISIN
- US6388423021
- LEI
- 549300QOT5V1NZ8WZY48
- EIN
- 84-1007839
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Mark A. Ledoux | CEO/Chairman, Director | 743,558 |
| Kenneth Wolf | President, COO, & Sec. | 126,831 |
| Michael E. Fortin | Chief Financial Officer | 58,739 |
| Alan G. Dunn | Director | 99,211 |
| Laura Kay Matherly | Director | 42,000 |
| Guru Ramanathan | Director | 38,000 |
CEO pay and shareholder return
Pay versus performance table from the proxy statement
| Fiscal year | CEO total pay | CEO pay actually paid | Other executives (avg) | Value of $100 invested | Peer group |
|---|---|---|---|---|---|
| FY2025 | $562.52K | $494.46K | $382.00K | $-46 | – |
| FY2024 | $794.01K | $760.41K | $529.21K | $-16 | – |
| FY2023 | $915.15K | $832.28K | $571.94K | $-31 | – |
| FY2022 | $954.27K | $828.15K | $589.59K | $-38 | – |
“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.
Employees
Headcount reported in annual reports
“As of June 30, 2026, we employed 219 employees in the U.S., 46 who were employed in research, laboratory and quality control, 10 in sales and marketing, and 162 in manufacturing and administration.”
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| May 18, 2026 | Late filing | Notification of late filing |
| Aug 24, 2021 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| Jun 9, 2021 | Listing notice | Notice of delisting or failure to satisfy a listing rule (8-K Item 3.01) |
| Jan 15, 2015 | Auditor change | Change in certifying accountant (8-K Item 4.01) |
| Aug 4, 2009 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| Aug 8, 2008 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| Sep 28, 2007 | Late filing | Notification of late filing |
| Dec 9, 2005 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| Oct 1, 2001 | Late filing | Notification of late filing |
| Sep 28, 2000 | Late filing | Notification of late filing |